Journal article
Effect of Odanacatib on BMD and Fractures: Estimates from Bayesian Univariate and Bivariate Meta-analyses
Abstract
CONTEXT: Odanacatib (ODN), a selective cathepsin-K inhibitor, was found to increase bone mineral density (BMD); the effect on fractures is based on adverse event reports.
OBJECTIVE: To estimate current effects and predict future effects of ODN on BMD and fractures.
Authors
Gajic-Veljanoski O; Tomlinson G; Srighanthan J; Adachi JD; Josse R; Brown JP; Cheung AM
Journal
The Journal of Clinical Endocrinology & Metabolism, Vol. 99, No. 9, pp. 3070–3079
Publisher
The Endocrine Society
Publication Date
September 1, 2014
DOI
10.1210/jc.2014-1162
ISSN
0021-972X